BlueGnome Launches BlueFuse Multi v2.0 arrayCGH Analysis Software
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: 1 minute
BlueGnome has announced the latest release of their arrayCGH analysis and database software, BlueFuse Multi at the Human Genetics Society of Australia meeting in Freemantle.
Rapid increases in both the resolution and number of microarrays being used in arrayCGH investigations are driving an explosion in the amount of data being generated in cytogenetics laboratories. At the same time more detailed reporting of gene content and the increased awareness of benign copy number variation in the normal population is limiting both the speed and confidence with which samples may be reported.
The new release of BlueFuse Multi addresses this problem by delivering fully automated data analysis with sophisticated visualization and reporting of copy number imbalances. Nick Haan, CEO of BlueGnome, commented, “Central to BlueFuse Multi v2.0 is DecisionTrack which visualizes each imbalance against tracks of gene content and CNV frequency downloaded from the major online data sources. DecisionTrack also summarizes the extents and frequencies of all imbalances in the database to enable “click through” access to the phenotypes of samples sharing a common imbalance”.
In order to ensure laboratory staff benefit from immediate access to all arrayCGH results unlimited software licenses are provided free of charge with all CytoChips.
Tony Lialin, Director of North American Sales, added; “Laboratories are tasked with generating reports, not results, or even data. BlueFuse Multi provides our customers with the software tools they require to fully exploit results generated in their own lab and in the wider scientific community in order to improve the quality and confidence of reporting. This realization is driving a rapid adoption of the new CytoChip Oligo platform here in North America, in fact we’ve added three new CytoChip labs here in North America in just the last 45 days.”
Rapid increases in both the resolution and number of microarrays being used in arrayCGH investigations are driving an explosion in the amount of data being generated in cytogenetics laboratories. At the same time more detailed reporting of gene content and the increased awareness of benign copy number variation in the normal population is limiting both the speed and confidence with which samples may be reported.
The new release of BlueFuse Multi addresses this problem by delivering fully automated data analysis with sophisticated visualization and reporting of copy number imbalances. Nick Haan, CEO of BlueGnome, commented, “Central to BlueFuse Multi v2.0 is DecisionTrack which visualizes each imbalance against tracks of gene content and CNV frequency downloaded from the major online data sources. DecisionTrack also summarizes the extents and frequencies of all imbalances in the database to enable “click through” access to the phenotypes of samples sharing a common imbalance”.
In order to ensure laboratory staff benefit from immediate access to all arrayCGH results unlimited software licenses are provided free of charge with all CytoChips.
Tony Lialin, Director of North American Sales, added; “Laboratories are tasked with generating reports, not results, or even data. BlueFuse Multi provides our customers with the software tools they require to fully exploit results generated in their own lab and in the wider scientific community in order to improve the quality and confidence of reporting. This realization is driving a rapid adoption of the new CytoChip Oligo platform here in North America, in fact we’ve added three new CytoChip labs here in North America in just the last 45 days.”
